$ACHN Company News 10 Nasdaq stocks with returns of at

New Post Public Reply Private Reply Replies (0) Message Board

Oct 1, 2014 at 9:35 AM

$ACHN Company News

10 Nasdaq stocks with returns of at least 240% in 2014 5:38 p.m. Sept. 11, 2014 - Philip van Doorn
5 stocks to watch 1:38 p.m. Sept. 3, 2014 - The Trading Deck
Six stocks to watch 1:47 p.m. Aug. 27, 2014 - The Trading Deck
S&P 500 reaches firmer technical ground 11:30 a.m. Aug. 18, 2014 - Michael Ashbaugh
Stocks trim Ukraine-inspired fall, post weekly gain 4:08 p.m. Aug. 15, 2014 - Anora Mahmudova
In focus: New highs premature? 9:03 p.m. June 18, 2014 - Lawrence G. McMillan
Achillion shares up; FDA lifts hold on hepatitis C drug 10:25 a.m. June 10, 2014 - Anna Prior
U.S. stock futures sink on shutdown fears 8:38 a.m. Sept. 30, 2013 - Barbara Kollmeyer
Zynga shares rise, Achillion drops after hours 5:51 p.m. July 1, 2013 - Wallace Witkowski
FDA puts Achillion Hep C drug on clinical hold 5:16 p.m. July 1, 2013 - MarketWatch.com
Five stocks making moves 3:12 p.m. Feb. 14, 2013 - The Trading Deck
Thursday’s top gaining & declining stocks 5:02 p.m. Sept. 27, 2012 - Greg Morcroft
Achillion sees progress in hepatitis C study 9:04 a.m. Sept. 27, 2012 - MarketWatch.com
Vertex to advance testing of oral HCV drug regimen 10:34 a.m. Sept. 25, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 4:37 p.m. Sept. 19, 2012 - MarketWatch
Achillion, Idenix move on price target changes 10:29 a.m. Sept. 19, 2012 - Val Brickates Kennedy
Gilead boosted as analysts hike price targets 10:42 a.m. Sept. 17, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 4:47 p.m. Aug. 16, 2012 - MarketWatch
Idenix plunges 30% on HCV drug setback 12:56 p.m. Aug. 16, 2012 - Val Brickates Kennedy
Bristol’s bad news is good for rivals: analysts 5:52 p.m. Aug. 2, 2012 - Val Brickates Kennedy

Achillion Pharmaceuticals, Inc. Less Attractive Amid Johnson & Johnson/Alios BioPharma Deal 11:19 a.m. Sept. 30, 2014 - benzinga.com
J&J Buying Alios, Going Up Against Gilead 11:02 a.m. Sept. 30, 2014 - Investors Business Daily
Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax 9:49 a.m. Sept. 30, 2014 - TheStreet.com
InsiderInsights.com Daily Round Up 9/26/14: CONN, AEO, OPK, RSG 9:20 a.m. Sept. 29, 2014 - Seeking Alpha
Following Biotech Stocks After Price Declines Of Greater Than 50% 4:03 p.m. Sept. 25, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 9/23/14: Apple, Ulta, Intersections, Republic Services 10:42 a.m. Sept. 24, 2014 - Seeking Alpha
If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits 8:00 a.m. Sept. 16, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ACHN BLUE LCI SLXP 7:30 a.m. Sept. 16, 2014 - InvestorPlace.com
'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks 5:00 a.m. Sept. 16, 2014 - TheStreet.com
Momentum Stocks Showing Weakness 4:33 p.m. Sept. 15, 2014 - benzinga.com
Midday Losers From September 15 - Tesla Motors Inc, Digital Ally, Inc. And More 11:56 a.m. Sept. 15, 2014 - benzinga.com
U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks 10:59 a.m. Sept. 15, 2014 - 247WallSt.com
Morning Market Losers 8:48 a.m. Sept. 15, 2014 - benzinga.com
Benzinga's Top #PreMarket Losers 7:15 a.m. Sept. 15, 2014 - benzinga.com
Morning Market Losers 8:45 a.m. Sept. 12, 2014 - benzinga.com
Benzinga's Top #PreMarket Losers 7:06 a.m. Sept. 12, 2014 - benzinga.com
Cramer's Mad Money - 2 Biotech Takeover Targets (9/11/14) 5:47 a.m. Sept. 12, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Enjoy This Bull Market While It Lasts 7:47 p.m. Sept. 11, 2014 - TheStreet.com
Can the Rally in Achillion (ACHN) Shares Continue? - Tale of the Tape 10:58 a.m. Sept. 10, 2014 - Zacks.com
Hottest Healthcare Stocks Now – NPSP LGND AVNR AUXL 8:45 a.m. Sept. 10, 2014 - InvestorPlace.com

Critical Alerts For Achillion Pharmaceuticals, Dreamworks Animation, SunEdison, El Pollo Loco and Whole Foods Market Released By InvestorsObserver 9:31 a.m. Sept. 30, 2014 - PR Newswire - PRF
Biotech Stocks Technical Data - Medivation, Galectin Therapeutics, Ironwood Pharma, Achillion Pharma, and PDL BioPharma 9:05 a.m. Sept. 16, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, LightInTheBox, VoxelJet, Whole Foods Market and Disney Released By InvestorsObserver 9:31 a.m. Sept. 15, 2014 - PR Newswire - PRF
Technical Updates, Operational Milestones, Product Upgrades, and Energy Saving Programs - Research Reports on Achillion, DE, Honeywell, Lockheed Martin and L-3 Communications 8:35 a.m. Sept. 9, 2014 - PR Newswire - PRF
Global Hepatitis C Market 2014-2018 9:58 p.m. Sept. 8, 2014 - PR Newswire - PRF
Reveal Insider Trading for Facebook, Plug Power, Achillion Pharmaceuticals, Apple, Twitter, and Intel 8:55 a.m. Sept. 2, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, Intel, YY, JA Solar and Skullcandy Released By InvestorsObserver 9:31 a.m. Aug. 26, 2014 - PR Newswire - PRF
Biotechnology Stocks to Keep an Eye On 9:02 a.m. Aug. 20, 2014 - ACCESSWIRE
New Drug Launches, Technical Updates, New Facility, Clinical Trials Data, and Dividend Declarations - Research Reports on Covidien, Mylan, Baxter, Achillion and Perrigo 8:40 a.m. Aug. 20, 2014 - PR Newswire - PRF
Achillion Granted U.S. Patent for ACH-3102 and Structurally Related NS5A Inhibitors 4:06 p.m. Aug. 19, 2014 - GlobeNewswire
Achillion Achieves 100 Percent Sustained Virologic Response Rate (SVR4) From an Eight Week Phase 2 Trial Evaluating a Ribavirin-Free Regimen of ACH-3102 and Sofosbuvir for Genotype 1 HCV ("Proxy Study"

7:00 a.m. Aug. 15, 2014 - GlobeNewswire
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 8:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Achillion Reports Second Quarter and Six Month 2014 Financial Results 4:06 p.m. Aug. 7, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Synergy Resources, Invensense, JinkoSolar, and Harley-Davidson Released By InvestorsObserver 9:31 a.m. Aug. 5, 2014 - PR Newswire - PRF
Critical Alerts For Exelixis, Rocket Fuel, Netflix, Johnson & Johnson, and Achillion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 15, 2014 - PR Newswire - PRF
Technical Data on Health Care Sector Equities -- Research on Achillion Pharma, Novavax, Dendreon, and Exelixis 7:00 a.m. July 10, 2014 - PR Newswire - PRF
Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion 5:50 a.m. July 7, 2014 - PR Newswire - PRF
Achillion Pharmaceuticals Added to the Russell 2000 and Russell Microcap Indexes 4:06 p.m. July 1, 2014 - GlobeNewswire
Critical Alerts For Bank of America, Achillion Pharmaceuticals, Walmart, SunEdison, and Advanced Micro Devices Released By InvestorsObserver 9:31 a.m. June 17, 2014 - PR Newswire - PRF
If Achillion Pharmaceuticals (NASDAQ: ACHN) Investors Are Hoping for a Buyout, This is Not an Investment Strategy; Analyst Report by BrokerBank Securities, Inc. 7:00 a.m. June 13, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ecology Auto Parts Faces Class Action for Labor Code Violations

Legal Battle Unfolds: Employees Take a Stand Step right up, folks, and get a load of the latest legal rumble pitting employees against the big machine of Ecology Auto Parts, Inc. Operating out of California, these auto-wrecking giants are now staring down the barrel of a class action lawsuit alleging they're skimping on labor law essentials. The lawsuit, which the folks...

Suburban Propane Prepares for Fiscal 2026 Results Call

Setting the Stage for Suburban Propane's Performance Review Buckle up, folks. Suburban Propane Partners, L.P. is gearing up to spill the beans about their Fiscal 2026 performance. They'll be talking numbers bright and early on November 12, 2026, at 9:00 AM Eastern Time, and whether you're dialing in or logging online, you might just catch a glimpse of where the propane...

Limber Health's New Tool Set to Revolutionize Rehab

A Shift in Rehab Therapy Alright, it's not every day you see a seismic shift in the world of rehab therapy. Limber Health just dropped the mic with their brand-new Recovery Forecast. Built on the heftiest risk-adjusted patient outcomes database in the game, this tool aims to replace those old-school, single-snapshot forecasts with a full 90-day predictive outlook. If you...

Bose Grabs Skullcandy: A Bold Audio Acquisition Move

Bose Broadens Horizons with Skullcandy Acquisition Well, here's a twist that rattles my morning coffee mug: Bose goes and buys Skullcandy. That’s right, the audio bigwig known for polished sound just snapped up the edgier, younger sibling in earbuds. Bose ain't just playing with sound anymore; they're grabbing lifestyle by the horns, hoping Skullcandy's flair will shake...

LFG Charts New Path with Expanded Franchise Lineup

A Unique Approach to Franchise Expansion LFG, or Limitless Franchise Growth if you prefer function over flair, is taking its expansion game to a different level. Based out of Scottsdale, these savvy folks have just beefed up their portfolio to nine diverse brand partners. You’d think they’re all about boosting numbers, right? But nah, they're so picky you'd think...

CobbleStone & Chu Chua Tech: A Transformative Alliance

Breaking Down the CobbleStone and Chu Chua Collaboration We’re in a tough, interconnected world where tech innovation is racing against the clock. So, when CobbleStone Software raises its hand to join forces with Chu Chua Technology Services LLP, it’s like a shot of adrenaline for anyone invested in North America’s tech wave. Let’s pause and dive right in because...

NEXCOM Fortifies Academic Networks with NGFW Platforms

Shielding Academic Networks in a Digital Era NEXCOM's stepping up to the plate to tackle the runaway train that is digital education. With classrooms going virtual and everything but the kitchen sink being plugged online, it's no wonder our beloved academic institutions are scrambling to hold the fort against cyber threats. Enter NEXCOM with their Next-Generation Firewall...

CMCC Global Pioneers Tokenized Funds in El Salvador

A Bold Move into Tokenization Tokenization: it's the buzzword that's got folks scratching their heads and bankers keeping an extra bottle of aspirin in their desk drawers. CMCC Global is diving headlong into this brave new world, rolling out two tokenized fund-of-funds right under El Salvador's fresh digital asset rules. Now that's gutsy. The Partners in Innovation...

NJ Roads Spark Emmy Nod: A Public Affairs Win

Our Infrastructure Gets Its Due Sometimes, the real unsung heroes aren’t the ones under bright lights but those toiling under the sun. “Our Infrastructure Matters,” a TV and web program taking a hard-nosed look at what's keeping our roads from crumbling under the weight of millions, just landed its first-ever New York Emmy nomination. Yep, you heard it right. No,...

Third Eye Demands Fairer Terms for SkyAI Buyout

Revamping the SkyAI Tender Offer Third Eye's backing of Bastion Trading's push for better terms in SkyAI's tender offer has put a spotlight on those crafty boardroom maneuvers. Investors aren't exactly thrilled with the crumbs being thrown their way, and it's about time someone held the cooks accountable. Getting What's Owed Here's the gist of it: Third Eye's not asking...